Table 2.
Additional laboratory investigations obtained.
| Investigations | Patient range | Reference range |
|---|---|---|
| Cortisol, free | 0.18 µg/dL | |
| Cortisol, total | 7.2 µg/dL | 5–23 µg/dL |
| CK total | 160 | 5–130 U/L |
| Ferritin | 189 (H) | 10–60 ng/mL |
| Folate | 12.41 | 4–20 ng/mL |
| Free T4 | 0.3 (L) | 0.7–2 ng/dL |
| Iron, serum | 52 | 22–184 µg/dL |
| TIBC | 309 | 250–400 µg/dL |
| Iron saturation | 17 (L) | 27–44% |
| T3 total | 46 (L) | 90–230 ng/dL |
| Triglycerides | 131 | 28–129 mg/dL |
| TSH | 449.44 | 0.5–4.5 mIU/mL |
| LDH | 283 | 150–500 U/L |
| G6PD Quant | 10.5 | 8.8–13.4 U/g Hgb |
| Vitamin B-12 | 761 | 200–835 pg/mL |
| Vitamin D 25-hydroxy | 20.7 (insufficiency) | ≥20 ng/mL |
| Hemoglobin A | 98% | Latest units: % |
| Hemoglobin A2 | 2% | Latest units: % |
| HGB electrophoresis | Normal pattern | |
| ANA | Negative | |
| Antithyroglobulin Ab | <20 | ≤40 IU/mL |
| TPO Ab | <10 | ≤40 IU/mL |
Ab, antibody; ANA, antinuclear antibodies; CK, creatinine kinase; G6PD, glucose 6-phospate dehydrogenase; H, high; HGB, hemoglobin; L, low; LDH, lactate dehydrogenase; TIBC, total iron-binding capacity; TPO, thyroid peroxidase; TSH, thyroid-stimulating hormone.
This work is licensed under a